Jean‐François Gaussin

Author

Erasmus Hospital ORCID

Also Known As

J.-F. Gaussin, Jean-François Gaussin, Jean‐François Gaussin

Publications

683

Citations

H-Index

Concepts

All Affiliations

Erasmus Hospital Université Libre de Bruxelles

About

Jean‐François Gaussin is an author at Erasmus Hospital specializing in health sciences, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	24
2	Medicine	1	1	24
3	Cell Biology	1	1	24
4	Immunology	1	1	24
5	Pharmacology	1	1	24

Jean‐François Gaussin

Publications

669

Citations

H-Index

Page 1

	Year	Citations
Cardenolide-Induced Lysosomal Membrane Permeabilization Demonstrates Therapeutic Benefits in Experimental Human Non-Small Cell Lung Cancers Tatjana Mijatovic, Véronique Mathieu, Jean‐François Gaussin, Neoplasia	2006	134
2,2,2-Trichloro-<i>N</i>-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1<i>H</i>-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a Novel Nonhematotoxic Naphthalimide Derivative with Potent Antitumor Activity Eric Van Quaquebeke, Tine Mahieu, Patrick Dumont, Journal of Medicinal Chemistry	2007	126
The sodium pump α1 sub‐unit: a disease progression–related target for metastatic melanoma treatment Véronique Mathieu, Christine Pirker, Elisabeth Martin de Lassalle, Journal of Cellular and Molecular Medicine	2009	125
Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model Véronique Mathieu, Nancy De Nève, Marie Le Mercier, Neoplasia	2008	123
Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice Anne Mathieu, Myriam Remmelink, Nicky D’Haene, Cancer	2004	96
Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts Florence Lefranc, Syril James, Isabelle Camby, Journal of neurosurgery	2005	41
Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery? Francis Darro, Christine Decaestecker, Jean‐François Gaussin, PubMed ImmunologyAnti-cancer Drug DiscoveryMetronomic ChemotherapyMouse Leukemia ModelsTumor Biology	2005	24

Page 1